How are Your Patients who Smoke Using E-cigarettes?

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The 5 leading advocacy groups said the safety of people with obesity is at risk and called on the FDA to change clinical trial inclusion requirements and expedite labeling changes.

October 25th 2023

Lung Cancer Survival Improved Significantly Based on Early CT Screening: 20-Year Follow-Up Study Findings

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Early CT Screening Significantly Improves Survival in Lung Cancer image credit ©nerthuz/stock.adobe.com

November 28th 2023

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Early CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.

August 30th 2023

Dupilumab sBLA Submission for COPD Accelerated Based on Second Positive Phase 3 Trial Findings

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Abdominal Bloating Morphs into Pain and Vomiting: Seen in the ED

Dupilumab reduced COPD exacerbations by more than one-third in the phase 3 NOTUS trial, matching outcomes from the earlier BOREAS study this year.

small bowel obstruction, Seen in the emergency department / image credit ©Guschenkova/stock.adobe.com

Obesity Advocacy Groups Say Exclusion of People with Obesity from Drug Research Must Stop

A 62-year-old woman reports several days of abdominal bloating and vomiting that changed 2 hours ago into severe generalized pain. Review the bedside ultrasound, here.

Related Content

November 29th 2023

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The 5 leading advocacy groups said the safety of people with obesity is at risk and called on the FDA to change clinical trial inclusion requirements and expedite labeling changes.

October 25th 2023

Lung Cancer Survival Improved Significantly Based on Early CT Screening: 20-Year Follow-Up Study Findings

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

November 28th 2023

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Early CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.

August 30th 2023

Dupilumab sBLA Submission for COPD Accelerated Based on Second Positive Phase 3 Trial Findings

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Abdominal Bloating Morphs into Pain and Vomiting: Seen in the ED

Dupilumab reduced COPD exacerbations by more than one-third in the phase 3 NOTUS trial, matching outcomes from the earlier BOREAS study this year.